Table 2 Pearson correlation between lnleptin/BMI and clinical parameters in each group.
Controls (n = 100) | Stage 5 CKD Patients (n = 209) | No-PTX Patients Group (n = 152) | PTX Patients Group (n = 57) | |||||
---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | |
Age (years) | −0.050 | 0.621 | 0.107 | 0.125 | 0.092 | 0.262 | 0.157 | 0.244 |
Dialysis vintage (months) | NA | NA | −0.051 | 0.537 | 0.067 | 0.522 | −0.126 | 0.350 |
Systolic BP (mmHg) | −0.130 | 0.198 | −0.128 | 0.066 | −0.101 | 0.215 | −0.249 | 0.061 |
Diastolic BP (mmHg) | −0.169 | 0.092 | −0.184 | 0.008 | −0.140 | 0.085 | −0.318 | 0.016 |
Hemoglobin (g/l) | −0.546 | <0.001 | 0.117 | 0.091 | 0.172 | 0.034 | −0.003 | 0.982 |
Hematocrit (%) | −0.530 | <0.001 | 0.116 | 0.095 | 0.172 | 0.035 | 0.001 | 0.996 |
Glucose (mmol/l) | −0.175 | 0.081 | 0.134 | 0.054 | 0.155 | 0.056 | 0.024 | 0.859 |
Creatinine (μmol/l) | −0.477 | <0.001 | −0.201 | 0.003 | −0.278 | 0.001 | 0.149 | 0.268 |
Urea (mmol/l) | −0.200 | 0.046 | −0.167 | 0.016 | −0.231 | 0.004 | 0.076 | 0.572 |
HDL cholesterol (mmol/l) | 0.151 | 0.133 | −0.209 | 0.002 | −0.258 | 0.001 | −0.090 | 0.507 |
LDL cholesterol (mmol/l) | −0.114 | 0.259 | 0.164 | 0.017 | 0.131 | 0.109 | 0.335 | 0.011 |
TC (mmol/l) | −0.073 | 0.470 | 0.115 | 0.098 | 0.113 | 0.167 | 0.118 | 0.383 |
Triglyceride (mmol/l) | −0.080 | 0.429 | 0.320 | <0.001 | 0.308 | <0.001 | 0.372 | 0.004 |
TC/HDL cholesterol | −0.147 | 0.144 | 0.288 | <0.001 | 0.307 | <0.001 | 0.223 | 0.096 |
Albumin (g/l) | −0.177 | 0.078 | 0.225 | 0.001 | 0.171 | 0.035 | 0.442 | 0.001 |
Calcium (mg/dl) | −0.001 | 0.990 | 0.231 | 0.001 | 0.255 | 0.002 | 0.323 | 0.014 |
Phosphorus (mg/dl) | 0.369 | <0.001 | −0.006 | 0.927 | −0.088 | 0.281 | 0.263 | 0.048 |
lnALP | 0.081 | 0.425 | −0.062 | 0.373 | 0.063 | 0.444 | −0.287 | 0.031 |
lniPTH | 0.157 | 0.120 | −0.127 | 0.067 | −0.143 | 0.079 | −0.306 | 0.021 |